7-128974936-G-A

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_012470.4(TNPO3):​c.2205C>T​(p.Leu735Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0472 in 1,613,834 control chromosomes in the GnomAD database, including 2,233 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.042 ( 201 hom., cov: 32)
Exomes 𝑓: 0.048 ( 2032 hom. )

Consequence

TNPO3
NM_012470.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.981

Publications

12 publications found
Variant links:
Genes affected
TNPO3 (HGNC:17103): (transportin 3) The protein encoded by this gene is a nuclear import receptor for serine/arginine-rich (SR) proteins such as the splicing factors SFRS1 and SFRS2. The encoded protein has also been shown to be involved in HIV-1 infection, apparently through interaction with the HIV-1 capsid protein. Several protein-coding and non-coding transcript variants have been found for this gene. [provided by RefSeq, Apr 2020]
TNPO3 Gene-Disease associations (from GenCC):
  • autosomal dominant limb-girdle muscular dystrophy type 1F
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.37).
BP6
Variant 7-128974936-G-A is Benign according to our data. Variant chr7-128974936-G-A is described in ClinVar as Benign. ClinVar VariationId is 260262.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.981 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0768 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNPO3NM_012470.4 linkc.2205C>T p.Leu735Leu synonymous_variant Exon 18 of 23 ENST00000265388.10 NP_036602.1 Q9Y5L0-2A0A024R794B3KMX1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNPO3ENST00000265388.10 linkc.2205C>T p.Leu735Leu synonymous_variant Exon 18 of 23 1 NM_012470.4 ENSP00000265388.5 Q9Y5L0-2

Frequencies

GnomAD3 genomes
AF:
0.0415
AC:
6320
AN:
152136
Hom.:
200
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00784
Gnomad AMI
AF:
0.0318
Gnomad AMR
AF:
0.0329
Gnomad ASJ
AF:
0.0354
Gnomad EAS
AF:
0.0835
Gnomad SAS
AF:
0.0709
Gnomad FIN
AF:
0.113
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.0479
Gnomad OTH
AF:
0.0378
GnomAD2 exomes
AF:
0.0514
AC:
12937
AN:
251454
AF XY:
0.0540
show subpopulations
Gnomad AFR exome
AF:
0.00769
Gnomad AMR exome
AF:
0.0202
Gnomad ASJ exome
AF:
0.0341
Gnomad EAS exome
AF:
0.0809
Gnomad FIN exome
AF:
0.106
Gnomad NFE exome
AF:
0.0477
Gnomad OTH exome
AF:
0.0484
GnomAD4 exome
AF:
0.0478
AC:
69838
AN:
1461580
Hom.:
2032
Cov.:
30
AF XY:
0.0488
AC XY:
35449
AN XY:
727118
show subpopulations
African (AFR)
AF:
0.00747
AC:
250
AN:
33478
American (AMR)
AF:
0.0207
AC:
926
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0337
AC:
882
AN:
26136
East Asian (EAS)
AF:
0.0786
AC:
3118
AN:
39694
South Asian (SAS)
AF:
0.0760
AC:
6550
AN:
86236
European-Finnish (FIN)
AF:
0.0991
AC:
5295
AN:
53414
Middle Eastern (MID)
AF:
0.0531
AC:
306
AN:
5764
European-Non Finnish (NFE)
AF:
0.0447
AC:
49677
AN:
1111752
Other (OTH)
AF:
0.0469
AC:
2834
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
3225
6450
9674
12899
16124
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1818
3636
5454
7272
9090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0415
AC:
6319
AN:
152254
Hom.:
201
Cov.:
32
AF XY:
0.0455
AC XY:
3387
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.00782
AC:
325
AN:
41566
American (AMR)
AF:
0.0328
AC:
502
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0354
AC:
123
AN:
3472
East Asian (EAS)
AF:
0.0833
AC:
431
AN:
5176
South Asian (SAS)
AF:
0.0716
AC:
345
AN:
4818
European-Finnish (FIN)
AF:
0.113
AC:
1199
AN:
10592
Middle Eastern (MID)
AF:
0.102
AC:
30
AN:
294
European-Non Finnish (NFE)
AF:
0.0479
AC:
3256
AN:
68026
Other (OTH)
AF:
0.0374
AC:
79
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
302
604
907
1209
1511
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
86
172
258
344
430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0402
Hom.:
66
Bravo
AF:
0.0326
Asia WGS
AF:
0.0900
AC:
314
AN:
3478
EpiCase
AF:
0.0505
EpiControl
AF:
0.0481

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Feb 26, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Autosomal dominant limb-girdle muscular dystrophy type 1F Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.37
CADD
Benign
6.0
DANN
Benign
0.79
PhyloP100
0.98
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2293493; hg19: chr7-128614990; COSMIC: COSV55285534; COSMIC: COSV55285534; API